Patients' tolerance of transrectal ultrasound-guided prostatic biopsy: an audit of 104 cases.
OBJECTIVE
To determine the frequency and severity of complications following transrectal ultrasonography (TRUS) guided prostatic biopsy, and of pain during the procedure.


METHODS
The study included 129 men undergoing TRUS-guided prostatic biopsy who were asked to complete a questionnaire about pain and complications one week after biopsy.


RESULTS
Of the 104 men who completed the questionnaire, 24% found the procedure moderately to extremely painful and 19% felt that they had had significant complications afterward, the commonest of these being painful or difficult voiding (13%) and haematuria (11%). Systemic symptoms of fever or 'sweats' occurred in 6%, with a diagnosis of septicaemia in three men, despite antibiotic prophylaxis. However, acute urinary retention occurred in only one man. Of all patients, 20% saw their general practitioner within a week, all of whom were prescribed antibiotics in addition to those given prophylactically in hospital.


CONCLUSIONS
TRUS-guided biopsy is often a painful experience for patients and is commonly associated with complications, particularly voiding difficulties. Of particular concern were the three patients with septicaemia, and that one in five men felt sufficiently unwell to visit their doctor within a week of the procedure.
Crundwell
M C
MC
Department of Urology, University Hospital Birmingham, Birmingham, UK.
Cooke
P W
PW
Wallace
D M
DM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D001424:Bacterial Infections / Q000517:prevention & control; D001707:Biopsy, Needle / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008485:Medical Audit; D010149:Postoperative Pain / Q000209:etiology*; D011467:Prostate / Q000473:pathology*; D011469:Prostatic Diseases / Q000473:pathology*; D018805:Sepsis / Q000209:etiology; D018084:Ultrasonography, Interventional; D014552:Urinary Tract Infections / Q000209:etiology / Q000517:prevention & control
D000900:Anti-Bacterial Agents